For Q2 2024, the Voya MidCap Opportunities Strategy underperformed its benchmark on a NAV basis due to unfavorable allocation ...

Charles River Lbrtrs ntrntl Inc (CRL) stock saw a decline, ending the day at $200.62 which represents a decrease of $-3.15 or -1.55% from the prior close of $203.77. The stock opened at $205.01 and ...

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on Charles River Labs (CRL – Research Report) today and set a price ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

After several years spent honing its robotic cell therapy manufacturing system, Multiply Labs has snared its first ...

Volunteers along the Fox River, including Cub Scouts, joined an annual clean-up event to remove trash and protect the local ...

General Hospital spoilers tease that Jack Brennan (Charles Mesure) is sticking around Port Charles for the foreseeable future. Mesure has been upped to contract status as of the credits list on ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $218.3, with a ...

Charles River Laboratories International, Inc. CRL and CEBINA GmbH (Central European Biotech Incubator and Accelerator) have formed a strategic alliance under the DanubeNeuro acceleration program — an ...

Just a few months after the reveal of Ori Biotech’s automated cell and gene therapy manufacturing platform IRO, the technical ...

Charles River Laboratories (NYSE: CRL) is reducing its workforce by about 3% as part of broader cost-cutting efforts. The ...